Tamoxifen may be getting help in fight against breast cancer

05/3/2004 | Forbes

A new class of aromatase inhibitors has shown promise in tests against breast cancer, but experts are saying tamoxifen, the traditional treatment for the past 20 years, should not be counted out just yet. Tamoxifen might remain the first-line treatment for women with breast cancer, while aromatase inhibitors could become a good backstop for those who cannot tolerate tamoxifen.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ